Manulife (Manufacturers Life Insurance)
BNGO icon

Manulife (Manufacturers Life Insurance)’s Bionano Genomics BNGO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-193
Closed -$129K – 2974
2023
Q1 		$129K Hold
193
– – ﹤0.01% 2688
2022
Q4 		$169K Sell
193
-3
-2% -$3.77K ﹤0.01% 2636
2022
Q3 		$215K Sell
196
-8
-4% -$10.6K ﹤0.01% 2546
2022
Q2 		$169K Buy
204
+5
+3% +$5.14K ﹤0.01% 2731
2022
Q1 		$309K Sell
199
-46
-19% -$62.1K ﹤0.01% 2497
2021
Q4 		$439 Buy
245
+1
+0.4% +$2.67K ﹤0.01% 2352
2021
Q3 		$807K Sell
244
-19
-7% -$66.5K ﹤0.01% 1973
2021
Q2 		$1.16M Buy
+263
New +$1.04M ﹤0.01% 1907

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s BNGO Position: Q2 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 193 shares — an estimated $129K sold.

Manulife (Manufacturers Life Insurance) first reported a position in BNGO in Q2 2021 and held it in 8 quarters. The position peaked at $1.16M in Q2 2021. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 193 Bionano Genomics shares in Q2 2023, an estimated $129K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Bionano Genomics in Q2 2021 and held it in 8 quarters.
  • Manulife (Manufacturers Life Insurance)'s Bionano Genomics position peaked at $1.16M in Q2 2021.
  • 108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2023, filed 11 Aug 2023.